HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFß pathway in pancreatic cancer.
Oncotarget
; 13: 747-754, 2022.
Article
in En
| MEDLINE
| ID: mdl-35634239
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Homeodomain Proteins
/
Carcinoma, Pancreatic Ductal
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oncotarget
Year:
2022
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos